eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Ipsen Ltd

190 Bath Road, Slough, Berkshire, SL1 3XE
Telephone: +44 (0)1753 627 777
Fax: +44 (0)1753 627 778
Medical Information Direct Line: +44 (0)1753 627 777
Medical Information e-mail: medical.information.uk@ipsen.com
Customer Care direct line: +44 (0)1753 627 627

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 25/10/2010
PIL Somatuline LA

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/10/2010 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 12/06/2009 and displayed until 25/10/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 01/11/2007 and displayed until 12/06/2009
Reasons for adding or updating:
  • Changes to therapeutic indications
  • Change to date of revision
Updated on 30/01/2002 and displayed until 01/11/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 26/08/2001 and displayed until 30/01/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 06/02/2001 and displayed until 26/08/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   lanreotide